McCullough Protocol©: Nasal-Oral Viricidal Washes and Gargles

Oct 2022

Everyone is familiar with nasal and oral swab testing for COVID-19.  It should be obvious the virus is replicating in the nose, and with Omicron, the speed of replication has become much greater than the prior strains of the virus.  Thus, there is a wonderful opportunity to reduce viral replication, in fact, kill viruses with agents directly applied in the nasal cavity and the back of the throat.  

Use of directly applied therapy is far more effective than swallowing pills or capsules or receiving an intravenous infusion.  The nasal mucosa is a barrier for entry and if functioning well, allows little penetration of virions into systemic circulation where for example a monoclonal antibody could work.  Thus, the McCullough Protocol© starting in 2021, featured the upfront use of nasal washes and oral gargles using viricidal agents.[ii]  

Many have asked which solutions, mixtures, and frequencies should be used?   One should be reassured that is far more important to use some form of nasal and oral topical therapy as opposed to letting the infection take its course and ultimately invade the lungs and the internal organs. 

For purposes of this stack, we acknowledge that many can be effective including:  povidone-iodine, hydrogen peroxide, colloidal silver, xylitol, and for the throat many mouthwashes including Scope and Listerine. 

Principles are 1) nasal solutions should be comfortable and not sting with sufficient dilution, 2) sniffed far back into the sinuses and then spit out through the mouth (often causes coughing or mild choking), done at least twice per nostril per session, 3) oral gargles should be for 30 seconds and then spit out. 

For detailed descriptions of products and solutions please visit one of several websites to get this practical information.[iii] 

Oropharyngeal viricidal therapy has been demonstrated in supportive studies and randomized trials to:  1) prevent infection after suspected exposure (twice daily), 2) reduce the period of infectivity when ill, and 3) attenuate the progression of disease and reduce the need for oxygenation and hospitalization (six times daily). 

https://petermcculloughmd.substack.com/p/mccullough-protocol-nasal-oral-viricidal?utm_source=substack&utm_campaign=post_embed&utm_medium=email

Leave a Reply